Back
Universe Pharmaceuticals Vs. Bowman Consulting Group Industry Stock Comparison
Sell
45
UPC
Universe Pharmaceuticals
Last Price:
2.34
Seasonality Move:
-39.01%
Sell
33
BWMN
Bowman Consulting Group
Last Price:
30.35
Seasonality Move:
-0.83%
Sell
45
Universe Pharmaceuticals (UPC)
is a Sell
Is Universe Pharmaceuticals a Buy, Sell or Hold?
- The current Universe Pharmaceuticals [UPC] share price is $2.17. The Score for UPC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- UPC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Bowman Consulting Group (BWMN)
is a Sell
Is Bowman Consulting Group a Buy, Sell or Hold?
- The current Bowman Consulting Group [BWMN] share price is $31.81. The Score for BWMN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BWMN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UPC Stock Price Chart
What is Universe Pharmaceuticals's stock price today?
-
The Universe Pharmaceuticals share price today is $2.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPC is experiencing slight buying pressure.
BWMN Stock Price Chart
What is Bowman Consulting Group's stock price today?
-
The Bowman Consulting Group share price today is $31.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BWMN is experiencing slight selling pressure.
UPC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 51 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.9 - 2.3) | Buy |
| Bollinger Bands (100): | (1.57 - 2.29) | Buy |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 47.49 | Sell |
| Chaikin Money Flow: | -21670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.6 - 32.6) | Buy |
| Bollinger Bands (100): | (30.81 - 36.55) | Sell |
UPC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.22 | Sell |
| 20-day SMA: | 2.19 | Sell |
| 50-day SMA: | 2.01 | Buy |
| 200-day SMA: | 1.6 | Buy |
| 8-day EMA: | 2.22 | Sell |
| 20-day EMA: | 2.17 | Sell |
| 50-day EMA: | 2.05 | Buy |
| 200-day EMA: | 2.14 | Buy |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.6 | Buy |
| 20-day SMA: | 31.47 | Buy |
| 50-day SMA: | 34.06 | Sell |
| 200-day SMA: | 31.54 | Buy |
| 8-day EMA: | 31.9 | Sell |
| 20-day EMA: | 32.06 | Sell |
| 50-day EMA: | 32.94 | Sell |
| 200-day EMA: | 31.6 | Buy |
Universe Pharmaceuticals Earnings Growth & UPC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bowman Consulting Group Earnings Growth & BWMN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.34 per share.
Universe Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||